Cornell Stamoran BSA

Cornell Stamoran serves as Vice President of Strategy & Corporate Development for Catalent Pharma Solutions, the leading global provider of development solutions and advanced delivery technologies for drugs, biologics, and consumer health products.

Mr. Stamoran leads Catalent’s strategic planning and market intelligence efforts, as well as supporting its global M&A and technology acquisition activities. He also serves at Catalent’s investor relations officer. Cornell has spent nearly 25 years engaged with the health care industry, including 20 years’ in advanced drug delivery.

Cornell has been fortunate to experience the realities of patient adherence and outcomes enhancement from almost every stakeholder perspective. Cornell has gained frontline experience on the realities of patient adherence and outcomes enhancement, from direct engagement with retail and hospital pharmacists; medical professionals; specialty pharmacies and clinics; PBMs; and payors. Cornell has directly participated in the development of drug design-enabled adherence and outcomes enhancement strategies for more than 150 branded drugs over the last 10 years.